Journal Mobile Options
Table of Contents
Vol. 9, No. 2, 2003
Issue release date: April 2003
Section title: Research Report
Eur Addict Res 2003;9:94–100
(DOI:10.1159/000068807)

Drug Consumption Rooms in Rotterdam: An Explorative Description

van der Poel A. · Barendregt C. · van de Mheen D.
Addiction Research Institute Rotterdam (IVO, Instituut voor Onderzoek naar Leefwijzen Verslaving), Rotterdam,TheNetherlands

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Research Report

Published online: 3/24/2003
Issue release date: April 2003

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 4

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: http://www.karger.com/EAR

Abstract

The Rotterdam Drug Monitoring System used survey data, fieldnotes and interviews with staff to investigate the functioning of four (out of six) consumption rooms in Rotterdam. The results show that for most drug users, access to the drug consumption room results in less frequent drug use in public places and more time and rest. Pass holders value being able to use drugs safely inside, and make use of the additional services provided, such as refreshments, washing/showering facilities and talking with others about their personal problems. Two ‘weak points’ reported by the drug users are discussed in relation to their personal health situation and public nuisance reduction.

© 2003 S. Karger AG, Basel


  

Author Contacts

Dr. Agnes van der Poel
Addiction Research Institute Rotterdam, IVO
Heemraadssingel 194
NL–3021 DM Rotterdam (The Netherlands)
Tel. +31 10 425 33 66, Fax +31 10 276 39 88, E-Mail vanderpoel@ivo.nl

  

Article Information

Number of Print Pages : 7
Number of Figures : 0, Number of Tables : 4, Number of References : 8

  

Publication Details

European Addiction Research

Vol. 9, No. 2, Year 2003 (Cover Date: April 2003)

Journal Editor: M. Krausz, Hamburg; A. Uchtenhagen, Zürich; C. Haasen, Hamburg
ISSN: 1022–6877 (print), 1421–9891 (Online)

For additional information: http://www.karger.com/ear


Article / Publication Details

First-Page Preview
Abstract of Research Report

Published online: 3/24/2003
Issue release date: April 2003

Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 4

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: http://www.karger.com/EAR


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.